ECSP045162A - "composiciones farmaceuticas a base de derivados de azetidina" - Google Patents

"composiciones farmaceuticas a base de derivados de azetidina"

Info

Publication number
ECSP045162A
ECSP045162A EC2004005162A ECSP045162A ECSP045162A EC SP045162 A ECSP045162 A EC SP045162A EC 2004005162 A EC2004005162 A EC 2004005162A EC SP045162 A ECSP045162 A EC SP045162A EC SP045162 A ECSP045162 A EC SP045162A
Authority
EC
Ecuador
Prior art keywords
pharmaceutical compositions
compositions based
azetidine derivatives
azetidine
derivatives
Prior art date
Application number
EC2004005162A
Other languages
English (en)
Inventor
Sophie Cote
Valerie Bobineau
Maria-Teresa Peracchia
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of ECSP045162A publication Critical patent/ECSP045162A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Psychiatry (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
EC2004005162A 2001-12-21 2004-06-18 "composiciones farmaceuticas a base de derivados de azetidina" ECSP045162A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0116638A FR2833842B1 (fr) 2001-12-21 2001-12-21 Compositions pharmaceutiques a base de derives d'azetidine

Publications (1)

Publication Number Publication Date
ECSP045162A true ECSP045162A (es) 2004-08-27

Family

ID=8870824

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2004005162A ECSP045162A (es) 2001-12-21 2004-06-18 "composiciones farmaceuticas a base de derivados de azetidina"

Country Status (32)

Country Link
EP (1) EP1458413B1 (es)
JP (1) JP5021887B2 (es)
KR (1) KR20040068308A (es)
CN (1) CN100388918C (es)
AP (1) AP1754A (es)
AR (1) AR037687A1 (es)
AU (1) AU2002364866B2 (es)
BR (1) BR0215048A (es)
CA (1) CA2470443A1 (es)
CO (1) CO5590911A2 (es)
DE (1) DE60233071D1 (es)
DK (1) DK1458413T3 (es)
EA (1) EA006510B1 (es)
EC (1) ECSP045162A (es)
FR (1) FR2833842B1 (es)
HK (1) HK1070840A1 (es)
HR (1) HRP20040575A2 (es)
HU (1) HUP0402586A3 (es)
IL (1) IL162563A0 (es)
MA (1) MA27086A1 (es)
ME (1) MEP16608A (es)
MX (1) MXPA04005558A (es)
MY (1) MY138172A (es)
NO (1) NO20042781L (es)
NZ (1) NZ533225A (es)
OA (1) OA12750A (es)
PL (1) PL203248B1 (es)
RS (1) RS55504A (es)
TW (1) TWI256304B (es)
UA (1) UA77736C2 (es)
WO (1) WO2003053431A2 (es)
ZA (1) ZA200404338B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1498122A1 (en) * 2003-07-18 2005-01-19 Aventis Pharma S.A. Semi-solid systems containing azetidine derivatives
EP1498123A1 (en) * 2003-07-18 2005-01-19 Aventis Pharma S.A. Emulsifying systems containing azetidine derivatives
WO2005077897A1 (en) 2004-02-17 2005-08-25 Laboratorios Del Dr. Esteve S.A. Substituted azetidine compounds, their preparation and use as medicaments
FR2879932B1 (fr) * 2004-12-27 2007-03-23 Aventis Pharma Sa Formulations injectable ou administrable par voie orale de derives d'azetidine
AU2006264649A1 (en) 2005-06-30 2007-01-11 Prosidion Limited GPCR agonists
GB0700122D0 (en) 2007-01-04 2007-02-14 Prosidion Ltd GPCR agonists
AR064736A1 (es) 2007-01-04 2009-04-22 Prosidion Ltd Agonistas de gpcr
WO2008081204A1 (en) 2007-01-04 2008-07-10 Prosidion Limited Piperidine gpcr agonists
WO2008081208A1 (en) 2007-01-04 2008-07-10 Prosidion Limited Piperidine gpcr agonists
CL2008000018A1 (es) 2007-01-04 2008-08-01 Prosidion Ltd Compuestos derivados de heterociclos de nitrogeno y oxigeno, agonistas de gpcr; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de la obesidad, diabetes, sindrome metabolico, hiperlipidemia, toleranci
GB0720390D0 (en) 2007-10-18 2007-11-28 Prosidion Ltd G-Protein coupled receptor agonists
GB0720389D0 (en) 2007-10-18 2008-11-12 Prosidion Ltd G-Protein Coupled Receptor Agonists
FR2923719B1 (fr) * 2007-11-15 2009-11-20 Sanofi Aventis Compositions pharmaceutiques a base de derives d'azetidine
FR2928149B1 (fr) 2008-02-29 2011-01-14 Sanofi Aventis Composes derives d'azetidines, leur preparation et leur application en therapeutique
FR2946650B1 (fr) * 2009-06-16 2011-08-19 Sanofi Aventis Esters derives d'azetidines, leur preparation et leur application en therapeutique.
UA153183U (uk) 2022-10-27 2023-05-31 Андрій Валерійович Максимов Стаканчик для приготування напою

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR73668B (es) * 1978-11-21 1984-03-28 Hoffmann La Roche
US5631365A (en) * 1993-09-21 1997-05-20 Schering Corporation Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
HRP980026A2 (en) * 1998-01-20 1999-10-31 Pliva Pharm & Chem Works 1-izothiazolydinone derivatives of azetidine-2-ones, processes for the preparation and use thereof
WO2000003753A2 (en) * 1998-07-14 2000-01-27 Em Industries, Inc. Microdisperse drug delivery systems
FR2783246B1 (fr) * 1998-09-11 2000-11-17 Aventis Pharma Sa Derives d'azetidine, leur preparation et les medicaments les contenant
FR2805818B1 (fr) * 2000-03-03 2002-04-26 Aventis Pharma Sa Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant
FR2805810B1 (fr) * 2000-03-03 2002-04-26 Aventis Pharma Sa Compositions pharmaceutiques contenant des derives de 3- amino-azetidine, les nouveaux derives et leur preparation
FR2805817B1 (fr) * 2000-03-03 2002-04-26 Aventis Pharma Sa Compositions pharmaceutiques contenant des derives d'azetidine, les nouveaux derives d'azetidine et leur preparation
FR2814678B1 (fr) * 2000-10-04 2002-12-20 Aventis Pharma Sa Association d'un antagoniste du recepteur cb1 et de sibutramine, les compositions pharmaceutiques les contenant et leur utilisation pour la traitement de l'obesite

Also Published As

Publication number Publication date
DE60233071D1 (de) 2009-09-03
EP1458413B1 (fr) 2009-07-22
AR037687A1 (es) 2004-12-01
UA77736C2 (en) 2007-01-15
KR20040068308A (ko) 2004-07-30
NZ533225A (en) 2007-02-23
WO2003053431A2 (fr) 2003-07-03
HUP0402586A2 (hu) 2005-03-29
NO20042781L (no) 2004-09-20
HK1070840A1 (en) 2005-06-30
CN1602206A (zh) 2005-03-30
MA27086A1 (fr) 2004-12-20
TW200301108A (en) 2003-07-01
CA2470443A1 (fr) 2003-07-03
AP2004003066A0 (en) 2004-06-30
MY138172A (en) 2009-04-30
FR2833842A1 (fr) 2003-06-27
AP1754A (en) 2007-07-18
CN100388918C (zh) 2008-05-21
MXPA04005558A (es) 2004-12-06
EP1458413A2 (fr) 2004-09-22
PL372708A1 (en) 2005-07-25
EA200400843A1 (ru) 2004-12-30
CO5590911A2 (es) 2005-12-30
ZA200404338B (en) 2005-06-02
FR2833842B1 (fr) 2004-02-13
IL162563A0 (en) 2005-11-20
MEP16608A (en) 2010-06-10
RS55504A (en) 2007-06-04
JP5021887B2 (ja) 2012-09-12
OA12750A (fr) 2006-07-03
DK1458413T3 (da) 2009-11-23
AU2002364866B2 (en) 2006-11-30
EA006510B1 (ru) 2005-12-29
HUP0402586A3 (en) 2011-05-30
TWI256304B (en) 2006-06-11
HRP20040575A2 (en) 2004-10-31
WO2003053431A3 (fr) 2003-12-18
PL203248B1 (pl) 2009-09-30
AU2002364866A1 (en) 2003-07-09
BR0215048A (pt) 2004-11-03
JP2005516945A (ja) 2005-06-09

Similar Documents

Publication Publication Date Title
IT1313549B1 (it) Formulazioni farmaceutiche a base di epotilone 3
HK1070840A1 (en) Pharmaceutical compositions based on azetidine derivatives
FI20011478A0 (fi) Farmaseuttinen koostumus
FI20105657A (fi) Farmaseuttisia koostumuksia
AR028204A1 (es) Composiciones farmaceuticas electrohiladas
PT1242087E (pt) Composicoes farmaceuticas
NO20033556L (no) Farmasöytiske formuleringer
EA199900373A3 (ru) Фармацевтические композиции
NO20040198L (no) Dolastatin 10 derivater
EE200300589A (et) Ravimkoostised
HUP0400850A3 (en) Oral pharmaceutical compositions
FI20022128A (fi) Farmaseuttinen koostumus
PT1239832E (pt) Composicoes farmaceuticas
DE60217390D1 (de) Bicalutamid enthaltende pharmazeutische zusammensetzung
NO20031095L (no) Farmasoytiske sammensetninger
IS7219A (is) Lyfjablanda sem inniheldur (R) -bíkalútamíð
PT1370141E (pt) Composicoes fungicidas a base de derivado de piridilmetilbenzamida e de propamocarbe
HK1068277A1 (en) Pharmaceutical compositions comprising chelidonineor derivatives thereof
MA27240A1 (fr) Derives d'imidazoquinoleine
DE10291905D2 (de) Pharmazeutische Zusammensetzung
EE200000459A (et) Farmatseutilised kompositsioonid
FR2809003B1 (fr) Compositions anti-pollution a base d'anthocyanes
IS7581A (is) Lyfjasamsetning
EE200300378A (et) Farmatseutiline kompositsioon
FR2814368B1 (fr) Preparation pharmaceutique a base d'oxans